GSK Announces £400m Relocation of Research HQ to Cambridge
GSK plans to relocate its research headquarters to Cambridge in a £400m move, aiming for all workers to transfer to Cambridge or Ware.
POLICY WIRE — London, UK — GlaxoSmithKline (GSK), one of the world’s leading pharmaceutical companies, has announced plans to relocate its research headquarters to Cambridge in a move estimated to cost £400 million. The company aims for all employees to transfer to either Cambridge or its site in Ware, Hertfordshire.
The decision is part of GSK’s strategy to consolidate its research operations in a single location, leveraging Cambridge’s reputation as a global hub for biotech and pharmaceutical innovation. The move is expected to enhance collaboration among scientists — and accelerate the development of new medicines.
GSK’s Chief Executive, Emma Walmsley, stated, “Cambridge is at the heart of the UK’s thriving life sciences sector. This move will enable us to bring together our world-class scientists in a state-of-the-art facility, fostering innovation and driving forward our mission to improve the health of millions of people worldwide.”
The new Cambridge facility will include advanced laboratories, collaborative workspaces, and cutting-edge technology to support GSK’s research and development activities. The company expects the relocation to be completed by 2025, pending necessary approvals — and construction timelines.
In addition to the Cambridge site, GSK will maintain its presence in Ware, where certain research functions will continue to operate. The company emphasized that it will work closely with employees to ensure a smooth transition, offering support and resources to those relocating.
The announcement has been met with enthusiasm from local authorities and business leaders in Cambridge, who view the move as a significant boost to the region’s economy and scientific community. Cambridge City Council Leader, Cllr Lewis Herbert, said, “We welcome GSK’s decision to establish its research headquarters in Cambridge. This is a testament to the city’s reputation as a leading center for innovation — and excellence in the life sciences.”
GSK’s relocation is expected to create hundreds of new jobs in Cambridge, further solidifying the city’s position as a key player in the global pharmaceutical industry. The company will also invest in community initiatives and partnerships to support local education and talent development in the life sciences.
Reporting by Policy-Wire (PW)
